W
WLC

Topic

NAD-therapy

3 articles on nad-therapy in longevity medicine. View all news →

Nature Aging: Emerging strategies, applications and challenges of targeting NAD+ in the clinic Peer-reviewed

NAD+ Therapy Clinics in 2026: IV NAD+, NR, NMN, Safety, and Evidence

NAD+ therapy clinics now sell IV NAD+, IV NR, NMN, and oral NR protocols. Here is the evidence, safety, regulatory context, costs, and buyer checklist for 2026.

NAD-therapy NMN NR
ScienceDaily: Scientists say NAD+ could slow aging and fight Alzheimer's and Parkinson's Peer-reviewed

NAD+ and Alzheimer's: What the Latest Research Actually Shows (2026)

A March 2026 Nature Aging review by 25+ scientists from the University of Oslo and international collaborators consolidates the evidence for NAD+ in neurodegenerative disease. Here's what the science says — and what it doesn't.

NAD-therapy Alzheimer-disease neurodegenerative-disease
Morningstar: Niagen Bioscience Announces Cruise Ship Clinic Partnership with OneSpaWorld

NAD+ on Cruise Ships: What Niagen's 80-Clinic Deal Means for Longevity Medicine

Niagen Bioscience is partnering with OneSpaWorld to offer pharmaceutical-grade NAD+ IV therapy at 80+ medi-spa clinics on high-end cruise ships starting summer 2026. Is this democratization or dilution of longevity medicine?

NAD-therapy longevity-industry cruise-ship-wellness